Answers are grounded in this paper and cite their sources.
Although subcutaneously implanted continuous glucose monitoring (CGM) devices have been shown to support diabetes self-management, their uptake remains low due to high costs and poor accuracy and precision arising from their invasiveness.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: